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Background: Avascular necrosis (AVN) refers to the death of osteocytes and osteoblasts. Sites
such as the femoral head, the head of the humerus and themandibulawith restricted access
to local blood supply are particularly vulnerable to osteonecrosis.
A combination of several factors is responsible for ischaemia and is associated with AVN:
corticosteroids, alcohol abuse, Cushing’s syndrome, SLE, systemic vasculitis, RA, sclero-
derma, haemoglobinopathies, radiotherapy. Management is based on proper diagnosis and
treatment – conservative, pharmacological or surgical.
Radiotherapy has become an integral part of the therapeutic programme of cancer
patients. However, early and late after-effects of irradiation still constitute a signiﬁcant issue
in clinical practice.
Aim: The aim of this report is to present two cases of acetabular protrusion and femoral
head deformities after a therapeutic pelvic irradiation and draw physicians’ attention to
that clinical problem which continues to be underestimated.
Materials and methods:This report documents two cases of acetabular protrusion and femoral
head deformities after a therapeutic pelvic radiation.
Results: Avascular necrosis (AVN) constitutes a severe and challenging long-term complica-
tion in radiation oncology.
Conclusion: It is necessary to take into account bone structures among organ at risk (OAR)
involved in irradiation ﬁelds. The detailed analysis of the dose distribution and the use ofcollimators allow to decrease the total dose to OAR.
An adequate management, early diagnosis and prompt, proper treatment may protect
patients from long-term morbidities.
land
and precise beam delivery. Rapid advance in radiobiology and© 2011 Greater Po
1. BackgroundNowadays, radiotherapy has become an integral part of the
therapeutic program of cancer patients. It represents a highly
effective and curative treatment modality for cervical can-
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cer, urinary bladder, prostate and rectum. Modern irradiation
planning techniques enable very accurate dose distributionphysics have had a great impact on understanding normal tis-
sue toxicities. However, early and late effects of irradiation
still constitute signiﬁcant issue in clinical practice. One of the
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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carcinoma, stage T2N0M0. In 1993, the patient was treated
with radiotherapy, delivered with 20MV photons, to the totalreports of practical oncology and
ost severe and challenging long-term complication in radio-
herapy is osteonecrosis, also called aseptic necrosis, ischemic
ecrosis or avascular necrosis (AVN).
This report documents extensive asymmetric bone abnor-
alities with an acetabular protrusion and femoral head
eformities, after a therapeutic pelvic radiation.
There is noparticular safe dose or tolerance dose. Theprob-
bility of radiation induced changes in bone (osteitis, fracture)
epends on many factors, such as dose per fraction, total
ose, dose intensity and irradiated volume. Tolerance doses
TD5/5–TD50/5), which represent the dose of radiation that
ould causenomore than5%and50%severe complication rate
ithin 5 years after irradiation, range from 20 to 30Gy and 65
o 70Gy for single and fractionated dose, respectively. As the
olume of irradiated bone or cartilage decreases, the dose to
roduce 5% or 50% complications increases. Bone structure,
ts location and patient’s age are also of great relevance.2,5,18
Avascular necrosis (AVN) refers to the death of osteo-
ytes and osteoblasts. There are at least two postulated
actors responsible for AVN. The cellular component depletion
aused directly by radiation and the local ischemia result-
ng from radiotherapy-induced microvascular damage. The
ubin & Cassaret theory explains the effect of irradiation
n microvasculature as a result of a slow vascular leak-
ge of the protein-rich ﬂuid leading to ﬁbrosis caused by
he accumulation of ﬁbroblasts and macrophages.19 Partic-
larly vulnerable to ischemic necrosis are the femoral head,
he femoral condyles, the head of the humerus, the capitu-
um and the proximal parts of the scaphoid and talus.13,16
ocated in the most distant parts of the bone’s vascular ter-
itories, these organs have restricted access to local blood
essels. The whole process may be caused by different clin-
cal situations, such as disturbance of the local blood supply,
enous stasis, intra-vascular thrombosis and compression of
apillaries by marrow swelling or a combination of several
f these factors.14 Various clinical conditions are associ-
ted with increased risk of AVN. They include corticosteroid
dministration, alcohol abuse, Cushing’s syndrome, Systemic
upus Erythematosus (SLE), systemic vasculitis, scleroderma,
olymyositis, dermatomyositis, haemoglobinopathies, radio-
herapy and fractured neck of the femur.1,3,4,9
. Aim
he aim of this report is to present two cases of acetabular
rotrusion and femoral head deformities after a therapeu-
ic pelvic irradiation and draw physicians’ attention to that
linical problem which continues to be underestimated.
. Materials and methods
.1. Case 1
65-year-old woman diagnosed with cervical cancer, stage
2N1M0 was treated with radical hysterectomy and postop-
rative radiotherapy in May 1995. Irradiation was delivered
sing a cobalt 60 unit with gamma rays. Total dose of 44Gy
as delivered in 2Gy per fraction using four ﬁeld (box tech-
ique), 5 days a week. The exact dose distribution within thetherapy 1 6 ( 2 0 1 1 ) 198–201 199
pelvis is not available, as a two-dimensional planning tech-
nique was used at that time. Nine years after therapy, the
patient started to feel pain in her right hip and the inguinal
region. The pain intensiﬁed with movement. A radiograph
showed signiﬁcant thinning of the bony structure in the right
femoral head. Bone metastases were excluded by a bone scan
which did not reveal any increase in the uptake at the right hip
joint. The patient was treated with anti-inﬂammatory medi-
cations. Eight months later she was qualiﬁed to orthopedic
operation and underwent curettage of the joint with bone
graft in May 2005. Pathological examination revealed focal
osteonecrosis. Although, the probability of radiation-induced
AVNwith dose below 50Gy is very low, about 5%within 5 years
after irradiation, a combination of several additional factors
such as long-term corticosteroid therapy, bone degeneration
or chemotherapy could be responsible for ischemia and bone
necrosis.1,3,5,18
3.2. Case 2
A 70-year-old man suffered from urinary bladder, urothelialeFig. 1 – Dose distribution of irradiated urinary bladder
cancer patient. (a) Frontal plane. (b) Transversal plane. The
isodose 60Gy is located out of the region of the femoral
heads.
d rad
r200 reports of practical oncology an
dose of 66Gy in 2Gy per fraction, one fraction per day, ﬁve days
per week. The four-ﬁeld ‘box’ technique was performed.
The patient remained asymptomatic for 3 years after treat-
ment, withoutmusculoskeletal symptoms. The ﬁrst symptom
of bone damage was a pathological fracture of the left
femur’s cervix. A radiograph revealed the fracture, mottled
the appearance of the femoral head, osteosclerosis and cyst
formations. The patient underwent a total hip arthroplasty.
Pathological examination conﬁrmed osteonecrosis. Dose vol-
ume histogram analysis showed that more than 60% volume
of irradiated tissues, including both femoral heads, were irra-
diated with 40–54Gy, but only 6% of femoral heads volume
received dose above 48Gy. Frontal and transversal dose distri-
butions of the treatment are shown in Fig. 1.
4. Results
In this study, two cases of AVN of the femoral head after
pelvic radiotherapy were presented. So far, there have been
few cases recognized and diagnosed, hence AVN still remains
poorly deﬁned and is an underestimated problem in oncol-
ogy. In both cases, these osseous abnormalities are thought
to be late consequences of the previous pelvis irradiation.6–8
Several radiographic staging systems are currently available.
According to the international classiﬁcation of the femoral
head osteonecrosis (Association Research Circulation Osseus
[ARCO]) and Ficat classiﬁcation, both patients were classiﬁed
as stage II AVN.2,10,17
5. Conclusion
The biological long term side effects of radiotherapy depend
on many factors, but the pathologic features are consistent.2
The dose volume histogram analysis of the bladder cancer
patient showed that mean dose in the region of both femoral
heads did not exceed acceptable dose of 50Gy. Four-ﬁeld “box”
technique has been a routine procedure used in treatment
of genitourinary cancers for many years and in majority of
cancer centers it is performed until now.11,12 In recent years,
an increase in genitourinary cancer cases has been reported,
which leads to a higher number of patients treatedwith pelvic
radiotherapy.13 Osteonecrosis constitutes a very difﬁcult diag-
nostic problem in long-term survivors, as the symptoms often
appear many years after radiotherapy and patients do not
associate them with past treatment.
Medical management includes avoidance of weight bear-
ing, the use of crutches and nonsteroidal anti-inﬂammatory
agents in early stages. Treatment of osteonecrosis is often
unsuccessful and nonsurgical procedures are very limited.
Analgesics can be used to minimize pain and inﬂammation
in patients who cannot be qualiﬁed for surgery for medi-
cal or other reasons. Physiotherapy plays a signiﬁcant role in
bringingmotion back and improving gait. The basic treatment
of osteonecrosis is surgery. Currently, there are many proce-
dures available. The choice is based on preoperative staging.
Core decompression and cortical bone grafting are usually
indicated in early stages. The trapdoor and allograft proce-
dures are indicated for Ficat II or III stages. Osteotomies areiotherapy 1 6 ( 2 0 1 1 ) 198–201
performed for stages II and III. Arthrodesis and arthroplasty
are used primarily for stages III and IV.1,15
Although AVN seems to be a very rare side-effect of radio-
therapy, clinicians must not forget about this complication, as
it may lead to severe functional impairment in patients who
often have been cured of cancer. An early diagnosis and proper
treatment may protect patients from long-term morbidities.
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